Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2025-12-03 00:00:00 ET · period of report 2025-12-01 · accession 0001193125-25-307215 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-12-03 | 2025-12-01 | GMED | Kline Kyle | SVP, CFO | M - OptEx | $59.86 | +18.5K | 18.5K | New | +$1.11M |
| DT | 2025-12-03 | 2025-12-01 | GMED | Kline Kyle | SVP, CFO | S - Sale+OE | $90.00 | -18.5K | 0 | -100% | -$1.67M |
| DMT | 2025-12-03 | 2025-12-01 | GMED | Kline Kyle | SVP, CFO | M - OptEx | $0.00 | -18.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-12-01 | M | A | 3,646 | $53.14 | 3,646 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-12-01 | M | A | 5,000 | $56.43 | 8,646 | D | — | — | |
| 3 | Common | Class A Common Stock | 2025-12-01 | M | A | 5,000 | $64.44 | 13,646 | D | — | — | |
| 4 | Common | Class A Common Stock | 2025-12-01 | M | A | 4,896 | $63.68 | 18,542 | D | — | — | |
| 5 | Common | Class A Common Stock | 2025-12-01 | S | D | 18,542 | $90.00 | 0 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2025-12-01 | M | D | 5,000 | $0.00 | 0 | D | $64.44 · — to 2031-01-25 | 5,000 Class A Common Stock | (F4) These options were granted on January 25, 2021 and are fully vested. |
| 7 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2025-12-01 | M | D | 5,000 | $0.00 | 10,000 | D | $56.43 · — to 2034-02-27 | 5,000 Class A Common Stock | (F3) These options were granted on February 27, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |
| 8 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2025-12-01 | M | D | 3,646 | $0.00 | 1,354 | D | $53.14 · — to 2033-03-24 | 3,646 Class A Common Stock | (F2) These options were granted on March 24, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |
| 9 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2025-12-01 | M | D | 5,000 | $0.00 | 0 | D | $63.68 · — to 2032-01-27 | 5,000 Class A Common Stock | (F5) These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |